Shire - 20 Year Stock Price History | SHPG

Historical daily share price chart and data for Shire since 1998 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Shire as of November 09, 2018 is 180.31.
Shire Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 159.8790 158.1561 181.8000 124.2024 180.3100 17.01%
2017 162.2271 173.9127 188.5599 137.3249 154.0932 -8.47%
2016 177.8970 195.0125 204.1102 147.8917 168.3593 -16.48%
2015 226.7907 204.9160 263.4621 185.4054 201.5811 -3.26%
2014 193.6812 135.9796 257.5642 135.9796 208.3769 50.95%
2013 105.4761 90.5801 138.0411 84.5315 138.0411 54.11%
2012 90.4386 99.9725 104.6640 80.1194 89.5743 -10.88%
2011 88.6206 70.4508 100.5238 69.9211 100.5046 44.20%
2010 63.8261 57.1520 71.3752 55.2169 69.6997 23.95%
2009 43.6597 43.2091 57.2861 30.6357 56.2324 32.20%
2008 47.9547 62.7577 65.5656 31.2314 42.5347 -34.75%
2007 65.7627 58.5226 75.1180 58.0986 65.1875 12.02%
2006 46.2717 37.2896 60.3977 36.2707 58.1928 59.84%
2005 32.6674 29.2180 36.8521 28.8856 36.4074 21.99%
2004 26.5158 27.1367 30.2037 22.1960 29.8438 10.16%
2003 19.7596 17.9637 27.2486 13.7501 27.0901 53.84%
2002 24.3970 33.9326 35.2843 17.1248 17.6095 -48.39%
2001 44.2087 42.8259 54.2455 32.4876 34.1190 -20.54%
2000 46.7922 27.9664 62.6354 26.3909 42.9377 58.12%
1999 23.6646 17.8332 32.6834 17.6002 27.1554 43.85%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $54.806B $15.161B
Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $45.773B 31.34
Grifols (GRFS) Spain $14.462B 17.65
Tilray (TLRY) United States $10.152B 0.00
Neurocrine Biosciences (NBIX) United States $9.559B 2108.20
Jazz Pharmaceuticals (JAZZ) Ireland $8.781B 12.60
Ionis Pharmaceuticals (IONS) United States $7.085B 0.00
Sage Therapeutics (SAGE) United States $6.139B 0.00
Impax Laboratories (AMRX) United States $5.895B 0.00
Nektar Therapeutics (NKTR) United States $5.888B 8.44
Catalent (CTLT) United States $5.453B 22.87
Loxo Oncology (LOXO) United States $5.106B 0.00
United Therapeutics (UTHR) United States $4.986B 8.15
Taro Pharmaceutical Industries (TARO) Israel $4.078B 15.10
FibroGen (FGEN) United States $3.574B 0.00
Endo (ENDP) Ireland $3.026B 4.64
USANA Health Sciences (USNA) United States $2.867B 24.40
Madrigal Pharmaceuticals (MDGL) United States $2.840B 0.00
Heron Therapeutics (HRTX) United States $2.212B 0.00
Aerie Pharmaceuticals (AERI) United States $2.171B 0.00
Xencor (XNCR) United States $2.130B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.036B 275.11
Endocyte (ECYT) United States $1.934B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.819B 0.00
PTC Therapeutics (PTCT) United States $1.703B 0.00
Corcept Therapeutics (CORT) United States $1.502B 22.05
Enanta Pharmaceuticals (ENTA) United States $1.473B 18.01
Esperion Therapeutics (ESPR) United States $1.461B 0.00
Zogenix (ZGNX) United States $1.460B 0.00
Portola Pharmaceuticals (PTLA) United States $1.458B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.439B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.430B 0.00
TESARO (TSRO) United States $1.382B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.275B 0.00
Tricida (TCDA) United States $1.251B 0.00
TherapeuticsMD (TXMD) United States $1.173B 0.00
ImmunoGen (IMGN) United States $0.884B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.844B 0.00
Radius Health (RDUS) United States $0.715B 0.00
Karyopharm Therapeutics (KPTI) United States $0.704B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.645B 0.00
Flexion Therapeutics (FLXN) United States $0.642B 0.00
GlycoMimetics (GLYC) United States $0.573B 0.00
Collegium Pharmaceutical (COLL) United States $0.513B 0.00
Akebia Therapeutics (AKBA) United States $0.511B 0.00
ChemoCentryx (CCXI) United States $0.508B 40.20
Xeris Pharmaceuticals (XERS) United States $0.484B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.482B 0.00
Dova Pharmaceuticals (DOVA) United States $0.476B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.475B 0.00
Odonate Therapeutics (ODT) United States $0.466B 0.00
OptiNose (OPTN) United States $0.448B 0.00
Dermira (DERM) United States $0.445B 0.00
ArQule (ARQL) United States $0.435B 0.00
Aquestive Therapeutics (AQST) United States $0.424B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.423B 24.88
Zafgen (ZFGN) United States $0.419B 0.00
Siga Technologies (SIGA) United States $0.405B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.399B 0.00
Forty Seven (FTSV) United States $0.397B 0.00
Mast Therapeutics (SVRA) United States $0.382B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.378B 0.00
Concert Pharmaceuticals (CNCE) United States $0.376B 0.00
Minerva Neurosciences (NERV) United States $0.371B 0.00
Depomed (ASRT) United States $0.347B 12.93
Aclaris Therapeutics (ACRS) United States $0.329B 0.00
Tapimmune (MRKR) United States $0.325B 0.00
Aratana Therapeutics (PETX) United States $0.324B 0.00
KalVista Pharmaceuticals (KALV) United States $0.323B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.308B 0.00
CASI Pharmaceuticals (CASI) United States $0.297B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.296B 0.00
Translate Bio (TBIO) United States $0.293B 0.00
Majesco Entertainment (PTE) United States $0.288B 0.00
ElectroCore (ECOR) United States $0.267B 0.00
IMV INC (IMV) Canada $0.256B 0.00
Affimed (AFMD) Germany $0.253B 0.00
Opexa Therapeutics (ACER) United States $0.242B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.240B 0.00
MEI Pharma (MEIP) United States $0.233B 0.00
Ocular Therapeutix (OCUL) United States $0.228B 0.00
Aldeyra Therapeutics (ALDX) United States $0.221B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.215B 0.00
Lannett Co Inc (LCI) United States $0.209B 1.82
Tyme Technologies (TYME) United States $0.208B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.207B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.203B 0.00
Neon Therapeutics (NTGN) United States $0.202B 0.00
Galectin Therapeutics (GALT) United States $0.196B 0.00
Ardelyx (ARDX) United States $0.189B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.189B 0.00
Calithera Biosciences (CALA) United States $0.185B 0.00
Redhill Biopharma (RDHL) Israel $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 0.00
ContraFect (CFRX) United States $0.174B 0.00
Molecular Templates (MTEM) United States $0.162B 0.00
Recro Pharma (REPH) United States $0.158B 0.00
Jounce Therapeutics (JNCE) United States $0.157B 0.00
Melinta Therapeutics (MLNT) United States $0.156B 0.00
Champions Oncology (CSBR) United States $0.154B 0.00
MediWound (MDWD) Israel $0.153B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.149B 0.00
DURECT (DRRX) United States $0.147B 0.00
Adherex Technologies (FENC) United States $0.145B 0.00
Infinity Pharmaceuticals (INFI) United States $0.136B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.132B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.131B 0.00
ProNAi Therapeutics (SRRA) Canada $0.123B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.115B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
Achaogen (AKAO) United States $0.104B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.100B 0.00
CTI BioPharma (CTIC) United States $0.099B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.089B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Iterum Therapeutics (ITRM) Ireland $0.080B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Otonomy (OTIC) United States $0.076B 0.00
BioLineRx (BLRX) Israel $0.074B 0.00
Forward Pharma (FWP) Denmark $0.072B 0.00
Natural Alternatives (NAII) United States $0.072B 8.01
Immune Design (IMDZ) United States $0.071B 0.00
Novan (NOVN) United States $0.068B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.065B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Trillium Therapeutics (TRIL) Canada $0.049B 0.00
Capnia (SLNO) United States $0.047B 0.00
SCYNEXIS (SCYX) United States $0.045B 0.00
Avenue Therapeutics (ATXI) United States $0.044B 0.00
KemPharm (KMPH) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.037B 0.00
Heat Biologics (HTBX) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Lipocine (LPCN) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Onconova Therapeutics (ONTX) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Xenetic Biosciences (XBIO) United States $0.025B 0.00
HANCOCK JAFFE (HJLI) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.021B 7.50
Pain Therapeutics (PTIE) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.019B 0.00
ESSA Pharma (EPIX) Canada $0.018B 0.00
Shineco (TYHT) China $0.017B 1.72
Aradigm (ARDM) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
Apricus Biosciences (APRI) United States $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
PharmAthene (ALT) United States $0.006B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00